REPL - Replimune Group, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - REPL (1737953)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
24 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-11-16
REPLXynos KonstantinosChief Medical OfficerS - Sale$10.92-7,313112,714-6%-$79,858
2023-11-16
REPLSarchi ChristopherChief Commercial OfficerS - Sale$10.92-5,25572,245-7%-$57,385
DM
2023-09-11
REPLEsposito PamelaChief Business OfficerS - Sale+OE$20.01-5,658263,436-2%-$113,214
D
2023-08-22
REPLEsposito PamelaChief Business OfficerS - Sale+OE$20.01-18,600263,436-7%-$372,186
D
2023-08-11
REPLEsposito PamelaChief Business OfficerS - Sale+OE$20.00-1,400263,436-1%-$28,000
D
2023-07-10
REPLEsposito PamelaChief Business OfficerS - Sale+OE$21.58-20,000263,436-7%-$431,541
2023-06-13
REPLLewis TanyaChief Dev. Op. OfficerS - Sale$24.06-12,860135,293-9%-$309,395
2023-06-13
REPLPatel SushilChief Strategy OfficerS - Sale$24.05-5,698148,873-4%-$137,008
2023-05-16
REPLPatel SushilChief Strategy OfficerS - Sale$18.05-15,575154,571-9%-$281,129
2023-05-16
REPLCoffin RobertPres, Chief R, D OfficerS - Sale$18.05-7,8611,833,3360%-$141,891
2023-05-16
REPLLewis TanyaChief Dev. Op. OfficerS - Sale$18.05-12,207148,153-8%-$220,336
2023-05-16
REPLLove ColinCOOS - Sale$18.05-10,775794,960-1%-$194,489
2023-05-16
REPLFranchi Jean M.CFOS - Sale$18.05-11,351128,748-8%-$204,886
2023-05-16
REPLXynos KonstantinosChief Medical OfficerS - Sale$18.05-771120,027-1%-$13,917
2023-05-16
REPLEsposito PamelaChief Business OfficerS - Sale$18.05-5,966263,436-2%-$107,686
2023-05-16
REPLAstley-Sparke PhilipCEOS - Sale$18.05-17,9021,525,278-1%-$323,131
D
2022-12-09
REPLEsposito PamelaChief Business OfficerS - Sale+OE$25.03-15,000229,402-6%-$375,450
2022-05-16
REPLLove ColinCOOS - Sale$14.59-6,324765,735-1%-$92,267
2022-05-16
REPLEsposito PamelaChief Business OfficerS - Sale$14.59-3,507229,402-2%-$51,167
2022-05-16
REPLFranchi Jean M.CFOS - Sale$14.59-3,43695,099-3%-$50,131
2022-05-16
REPLLewis TanyaChief Dev. Op OfficerS - Sale$14.59-5,473120,360-4%-$79,851
2022-05-16
REPLPatel SushilChief Commercial OfficerS - Sale$14.59-10,687130,146-8%-$155,923
2022-05-16
REPLCoffin RobertPres, Chief R, D OfficerS - Sale$14.59-5,7371,796,1970%-$83,703
2022-05-16
REPLAstley-Sparke PhilipCEOS - Sale$14.59-9,6321,401,080-1%-$140,531

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top